Mentored Investigator Grant
Funding Amount
US $100,000
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- University of California, San Francisco
- Magee-Womens Research Institute (University of Pittsburgh)
- University of California, Irvine
- Postdoctoral fellows and early-career investigators
Geography
- United States (based on current grantees)
Other requirements
- The Wistar Institute
- Memorial Sloan Kettering Cancer Center
- Must have doctoral degree (Ph
- D., M.D., or equivalent) in relevant field
Overview
Focus: Ovarian cancer research
Program Description
The Mentored Investigator Grant supports early-career researchers conducting ovarian cancer research. Recipients are postdoctoral fellows and early-career investigators working under mentorship at research institutions.
Research Focus Areas
Based on current grantees, the program funds research in:
- Cancer-associated fibroblasts and drug resistance
- Quiescent ovarian cancer cells and chemotherapy resistance
- IL-1α signaling and metastatic ovarian cancer
- Cancer stem cells and therapy resistance
- PARP inhibitor resistance in BRCA-associated ovarian cancer
- Long non-coding RNAs in cancer progression
Eligible Institutions
- University of California, San Francisco
- Magee-Womens Research Institute (University of Pittsburgh)
- The Wistar Institute
- University of California, Irvine
- Memorial Sloan Kettering Cancer Center
Eligibility
- Postdoctoral fellows and early-career investigators
- Must have doctoral degree (Ph.D., M.D., or equivalent) in relevant field
- Must be working under mentorship of established researcher
- Research must focus on ovarian cancer
What OCRA Funds
- Basic science research on ovarian cancer mechanisms
- Translational research aimed at developing new therapeutics
- Research addressing drug resistance and treatment failure
- Studies on immunotherapy and tumor microenvironment
Contact Information
- Website: ocrahope.org
- Research section: ocrahope.org/research/
- For researchers: Information for Researchers page available on website
What The Ovarian Cancer Research Fund Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 14
- Total given
- $5.67M
- Median grant
- $325K
- Range
- $75K–$900K
- By dollars: Virginia 16%, Minnesota 16%, Massachusetts 16%. Top recipient cities: Houston, TX; Ashburn, VA; Bagley, MN.
- 0% of grants with a stated purpose were for general or operating support.
- 64% of recipients were new grantees, not repeat recipients.
Example grants
The George Washington University · Ashburn, VA
Research
$900K
University of Minnesota · Bagley, MN
Research
$900K
Children's Hospital Corporation (DBA Boston Children's Hospital) · Boston, MA
Research
$899K
Northwestern University · Evanston, IL
Research
$550K
Washington University in St Louis · Saint Louis, MO
Research
$550K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Cancer
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
B4BC Survivorship Fund
Boarding for Breast Cancer Inc
Amount
Varies
Deadline
Rolling (quarterly review)
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $499,999
Deadline
January 7, 2027
Collaborative Research Development Grant
The Ovarian Cancer Research Fund Inc
Amount
Up to US $900,000
Deadline
Deadline not published
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $350,000
Deadline
November 6, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $300,000
Deadline
November 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$50,000 - $150,000
Deadline
November 10, 2026
Ready to apply for Mentored Investigator Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Mentored Investigator Grant. Now let's win it.